0.2630
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-83,527.0000
-99,185.0000
-163,953.0000
-98,142.0000
Investing Cash Flow
89,040.0000
-69,201.0000
-155,937.0000
-886.0000
Financing Cash Flow
--
1,710.0000
313,273.0000
309,753.0000
End Cash Position
104,445.0000
79,294.0000
248,182.0000
254,350.0000
Income Tax Paid Supplemental Data
-131.0000
375.0000
--
--
Capital Expenditure
-464.0000
-1,845.0000
-947.0000
-886.0000
Issuance of Capital Stock
--
--
314,083.0000
310,000.0000
Issuance of Debt
--
--
--
15,000.0000
Free Cash Flow
-83,991.0000
-101,030.0000
-164,900.0000
-99,028.0000
12/31/2020 - 11/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
085660.KQ Chabiotech Co.,Ltd.
11,570.00
-2.53%
FNAM Evolutionary Genomics, Inc.
0.0008
0.00%
LOBEF Lobe Sciences Ltd.
0.0019
0.00%
COOL.CN Core One Labs Inc.
0.1450
0.00%
SQZB SQZ Biotechnologies Company
0.0300
0.00%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
LOBE.CN Lobe Sciences Ltd.
0.0250
0.00%
CAMX.ST Camurus AB (publ)
601.00
+1.09%
GNS.L Genus plc
1,478.00
-0.40%
NAVB Navidea Biopharmaceuticals, Inc.
0.0001
0.00%